young woman in an smock
We are the leader
We are the leader of the Polish pharmaceutical market and one of the leading drug manufacturers in the region of Central and Eastern Europe. The beginning of our company dates back to 1935. Currently, we are part of a strong international pharmaceutical group, offering modern drugs, substances and innovative solutions for patients and business partners from around the world. 400 milion packages leave out our manufacturing plants every year.
Read more
We care
We want to help people live a healthy life in a healthy world, which guides everything we do. Social responsibility is an integral part of our daily work.
Read more
Laboratory worker during tests Laboratory worker during tests
We develop new products
We produce safe and convenient products for patients. We are also developing products in new, advanced areas, including ophthalmology, asthma and injection forms to help an increasing number of patients. We actively engage with the scientific community, by supporting young scientists and disseminating knowledge.
Read more
We are a successful employer
Polpharma is a workplace that motivates you to develop talent and choose your professional path. Our successes in this area have been recognised in the Pomeranian Employer of the Year, the Ideal Employer and the Employer of Health competitions.
Read more

News

See all
12 February 2025

Polpharma Receives Grants for Research Projects

Company News Science and Innovation News
LinkedIn Twitter Facebook Messenger Skopiuj link

Polpharma has been awarded grants for the implementation of two innovative research projects as part of a competition organized by the Medical Research Agency (ABM). This competition aimed to support the development of new pharmaceutical forms of medicinal products and generic drugs.

Among the awarded projects by Polpharma are:

  1. Development and advancement of inhaled complex generic drugs for the treatment of respiratory diseases such as COPD and asthma – this project aims to create modern medications that will improve the quality of life for patients with respiratory diseases.
  2. Development and advancement of an injectable generic drug based on an active substance from the polypeptide group for the treatment of type 2 diabetes – this project focuses on developing modern therapies for patients with type 2 diabetes.

These prestigious grants are evidence of Polpharma’s commitment to the development of innovative pharmaceutical solutions aimed at improving patients’ quality of life.

Read more

Polpharma in Numbers

89
years of history
Since 1935 our goal has been to help patients achieve a long and healthy life.
4345
employees of Polpharma
5
manufacturing plants
We have 5 manufacturing plants. In addition, we work on more patient-friendly drugs at 3 research and development centres.
woman in a bright dress on a white blue background

Acclaimed employer

4345 people employed at Polpharma help people live a healthy life in a healthy world.
Join us!
woman in a bright dress on a white blue background Join us!

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.